Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.348 SEK | +7.67% | +11.22% | -22.31% |
08/05 | Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
14/02 | Sprint Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
8.39M | - | - | - | |||
121B | ||||||
107B | ||||||
24.82B | - | |||||
22.48B | - | |||||
18.32B |